These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18812493)

  • 1. Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring.
    Zupan B; Toth M
    J Pharmacol Exp Ther; 2008 Dec; 327(3):820-6. PubMed ID: 18812493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotype.
    Zupan B; Toth M
    Neuropsychopharmacology; 2008 Oct; 33(11):2667-75. PubMed ID: 18172434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAB receptor-mediated feed-forward circuit dysfunction in the mouse model of fragile X syndrome.
    Wahlstrom-Helgren S; Klyachko VA
    J Physiol; 2015 Nov; 593(22):5009-24. PubMed ID: 26282581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.
    Pacey LK; Heximer SP; Hampson DR
    Mol Pharmacol; 2009 Jul; 76(1):18-24. PubMed ID: 19351745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
    Brennan FX; Albeck DS; Paylor R
    Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.
    Pacey LK; Tharmalingam S; Hampson DR
    J Pharmacol Exp Ther; 2011 Sep; 338(3):897-905. PubMed ID: 21636656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome.
    Kang JY; Chadchankar J; Vien TN; Mighdoll MI; Hyde TM; Mather RJ; Deeb TZ; Pangalos MN; Brandon NJ; Dunlop J; Moss SJ
    J Biol Chem; 2017 Apr; 292(16):6621-6632. PubMed ID: 28213518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-Baclofen Reverses a Social Behavior Deficit and Elevated Protein Synthesis in a Mouse Model of Fragile X Syndrome.
    Qin M; Huang T; Kader M; Krych L; Xia Z; Burlin T; Zeidler Z; Zhao T; Smith CB
    Int J Neuropsychopharmacol; 2015 Mar; 18(9):. PubMed ID: 25820841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments.
    Baker KB; Wray SP; Ritter R; Mason S; Lanthorn TH; Savelieva KV
    Genes Brain Behav; 2010 Aug; 9(6):562-74. PubMed ID: 20398059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse.
    Sørensen EM; Bertelsen F; Weikop P; Skovborg MM; Banke T; Drasbek KR; Scheel-Krüger J
    Behav Pharmacol; 2015 Dec; 26(8 Spec No):733-40. PubMed ID: 26110222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
    Wrenn CC; Heitzer AM; Roth AK; Nawrocki L; Valdovinos MG
    Neurosci Lett; 2015 Jan; 585():109-13. PubMed ID: 25433180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the
    Sinclair D; Featherstone R; Naschek M; Nam J; Du A; Wright S; Pance K; Melnychenko O; Weger R; Akuzawa S; Matsumoto M; Siegel SJ
    eNeuro; 2017; 4(1):. PubMed ID: 28451631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-asarone improves striatal cholinergic function and locomotor hyperactivity in Fmr1 knockout mice.
    Qiu G; Chen S; Guo J; Wu J; Yi YH
    Behav Brain Res; 2016 Oct; 312():212-8. PubMed ID: 27316341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits.
    Uutela M; Lindholm J; Louhivuori V; Wei H; Louhivuori LM; Pertovaara A; Akerman K; Castrén E; Castrén ML
    Genes Brain Behav; 2012 Jul; 11(5):513-23. PubMed ID: 22435671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of sensorimotor gating abnormalities in Fmr1 knockout mice carrying a human Fmr1 transgene.
    Paylor R; Yuva-Paylor LA; Nelson DL; Spencer CM
    Behav Neurosci; 2008 Dec; 122(6):1371-7. PubMed ID: 19045956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice.
    Westmark PR; Lyon G; Gutierrez A; Boeck B; Van Hammond O; Ripp N; Pagan-Torres NA; Brower J; Held PK; Scarlett C; Westmark CJ
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
    Qin M; Kang J; Smith CB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA(B) modulation of dopamine release in the nucleus accumbens core.
    Pitman KA; Puil E; Borgland SL
    Eur J Neurosci; 2014 Nov; 40(10):3472-80. PubMed ID: 25229321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.